Reuters Events Pharma’s Post

Say hello to Stefan Repin and Ahmed Kadous as they dive into what it means to increase #PatientAccess to everyone. As you all may already know, such a topic has become dire. We must connect with one another to implement meaningful work in pharma. It all comes down to how well we can collaborate. Check out the Podcast episode on our Youtube Channel ⬇️ #Pharma #PharmaInnovation #Innovation

In this episode of our podcast, Dr. Thomas Lönngren, Strategic Advisor at SSI Strategy and former Executive Director of the European Medicines Agency, shares essential strategies for: 📌Engaging regulators effectively 📌 Designing market-oriented clinical trials 📌 Navigating global biotech development challenges With three decades of experience in drug regulation, Thomas provides valuable insights to help you avoid common pitfalls and optimize your path from concept to market. Click the link below to listen and learn from his expertise. https://lnkd.in/drfQ6jsq

🚀 Part 2 of our insightful podcast with Craig Lipset is now live! After the insightful journey in Part 1, we dive even deeper in Part 2 https://lnkd.in/ewPEsZnB with Craig Lipset into transformative topics shaping the future of pharmaceuticals and healthcare: - Diversity, Equity, & Inclusion in clinical trials - Impact of tech acquisitions on pharma - Exploring the 'Biotech Mafia' - Evolution of site networks and edge machine learning - Generative AI: To Build or Buy? - The future of Decentralized Clinical Trials (DCT) - Craig’s indispensable advice to the next generation of industry leaders In case you missed it, https://lnkd.in/eBvjpZZG set the stage by exploring Craig’s journey and the transformative impact of patient-centric approaches in drug development. Together, these discussions offer a holistic view on not just where we are, but where we're headed in healthcare and pharmaceuticals. Tune into Part 2 for a deep dive into the technologies and strategies that are reshaping our industry. Whether you’re just starting out or are a seasoned professional, there's something in these conversations for you. Be inspired, be informed, and let’s lead the charge towards a healthier future. 🌟 👉 Don’t forget to catch up on Part 1 if you haven’t already!

Excited to participate in, and announce, the release of our inaugural Converge Episode! How can partnerships across the Quality of Life Ecosystem foster a patient-centric approach? Senior Vice President, Global Head of Patient Centricity at Astellas Pharma, Anthony Yanni MD, says that there is a shared aim to deliver value to patients as quickly and efficiently as possible across the pharmaceutical and healthcare industries, and that collaboration is key to ensuring access to care for patients regardless of regional or economic restrictions. Anthony, Shelly Carolan and I discuss this and more in WittKieffer's first Converge Cast, a new podcast series featuring leaders from across the Quality of Life Ecosystem discussing the issues that matter to the wellbeing of people and communities. #patientcentricity #pharmaceuticals #biotech #executivesearch #researchanddevelopment #commercialization #innovation WittKieffer

"We all want to do something meaningful in our lives, something that makes us proud of being alive, being people, being human." That's the principle I stand by and, frankly, the principle that the majority of people I met in my life shared too. Throughout numerous talks, panel discussions, interviews, or podcasts, I often get asked: why pharma? During the talk with Mehrnaz Campbell that took place as a part of her Digital Transformation Series, I had a chance to explain why. Surely, as an IT organization, Viseven could choose any area or field, but we keep sticking with "somewhat too regulated and conventional pharma." In essence, we are all pharma customers. Whether directly or indirectly, the pharmaceutical industry touches each of our lives. By partnering with pharma companies and facilitating improved communication, we are playing our part in creating a healthier, more connected world. And we believe that a connected and well-informed healthcare community is the cornerstone of progress. Is this contributing to a cause broad enough? To me, it is. #pharmaindustry #healthcare #purposedriven

It's incredibly important to stay commercially competitive in the ever-evolving biopharma industry. Huge investments into R&D and effort in crossing all regulatory hurdle to put a product into the market means only one thing: Successfully curing diseases while ensuring healthy return of investment. Ray Pressburger, Strategy Lead for Accenture Life Sciences, took part in the Fierce Pharma 'The Top Line' podcast to delve into what makes biopharma organizations commercially successful and how they can stay competitive. Listen to the podcast here: https://accntu.re/3Fs0R6D #Biopharma #LifeSciences #Innovation

Delighted to be a guest on the Platforce podcast and talking with Stefan Repin exploring marketing in the healthcare industry. Drawing from my background in pharma and medtech, the discussion dove into #agilemarketing and new #marketingtechnologies and how to adapt and implement. Grateful for the chance to share insights and learn from fellow experts! You can attend the podcast in #spotify🎙️or Platforce page. #HealthcareMarketing #Pharma #MedTech #PodcastGuest

Well worth a watch!!! The latest podcast from 4.0 Solutions discussing the first successful UNS deployment in pharma in Europe with John McKeon MIET and Gallarus Industry Solutions.

"Brandon Newman, CEO of healthcare analytics company Xevant, joins host Jonah Comstock on an episode of the pharmaphorum podcast. They discuss the oft-maligned role of pharmacy benefit managers, problems with the drug pricing provisions in the Inflation Reduction Act, the lack of (and importance of) price transparency, the various levers available to the government to address prices, and what companies like Xevant are doing right now to lower drug prices for patients." ⬇ Click below to listen to the episode!